Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion

Background: EGFR and ERBB2 exon 20 insertion (Ex20ins) account for a small fraction of patients with EGFR mutations. The efficacy of immune checkpoint inhibitors (ICIs) for these patients was still controversial. Methods: This retrospective study enrolled lung cancer patients harboring either EGFR o...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yue Zheng, Yang Fu, Yueyun Chen, Qing Li, Ting Liu, Zhenyu Ding
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2023-11-01
Col·lecció:	Current Oncology
Matèries:	EGFR ERBB2 exon 20 insertion immunochemotherapy lung cancer
Accés en línia:	https://www.mdpi.com/1718-7729/30/11/721
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!